SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-181337
Filing Date
2019-06-25
Accepted
2019-06-25 17:22:56
Documents
3
Period of Report
2019-06-24
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d766674d8k.htm 8-K 19859
2 EX-3.1 d766674dex31.htm EX-3.1 27930
3 EX-3.2 d766674dex32.htm EX-3.2 118777
  Complete submission text file 0001193125-19-181337.txt   167726
Mailing Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016 917-336-9310
Prevail Therapeutics Inc. (Filer) CIK: 0001714798 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38939 | Film No.: 19919414
SIC: 2836 Biological Products, (No Diagnostic Substances)